Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Richard P Gale

Showing results (11-20 of 35) with videos related to

Pageof 4
Sort By:
Eye (London, England)|March 30, 2024
An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspectiveAurelie Meunier, Oyin Opeifa, Louise Longworth, et al.
Eye (London, England)|January 10, 2026
Early detection of neovascular age-related macular degeneration in the second eye reduces intravitreal treatment burden: FASBAT report 2Rachel L W Hanson, Archana Airody, Sobha Sivaprasad, et al.
Ophthalmology. Retina|March 20, 2026
PULSAR: Clinical Outcomes of Aflibercept 8 mg with Extended Dosing and 2 mg in nAMD in Subgroups Defined by Baseline CharacteristicsRichard P Gale, Anat Loewenstein, Xin Zhang, et al.
Ophthalmology. Retina|December 30, 2021
Efficacy Outcomes of Brolucizumab Versus Aflibercept in Neovascular Age-Related Macular Degeneration Patients with Early Residual FluidRishi P Singh, Chirag Jhaveri, Charles C Wykoff, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 18, 2020
Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service DeliveryWinfried Amoaku, Clare Bailey, Louise Downey, et al.
Ophthalmology. Retina|January 3, 2024
Improved Structure and Function in Early-Detected Second-Eye Neovascular Age-Related Macular Degeneration: FASBAT/Early Detection of Neovascular Age-Related Macular Degeneration Report 1Richard P Gale, Archana Airody, Sobha Sivaprasad, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 30, 2017
Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 updatePraveen J Patel, Helen Devonport, Sobha Sivaprasad, et al.
Eye (London, England)|January 5, 2020
Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degenerationAdam H Ross, Louise Downey, Helen Devonport, et al.
Scientific Reports|March 27, 2023
Assessing the structure of the posterior visual pathway in bilateral macular degenerationHolly D H Brown, Richard P Gale, André D Gouws, et al.
Eye (London, England)|March 31, 2019
Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye serviceRichard P Gale, Sajjad Mahmood, Helen Devonport, et al.
Pageof 4

Showing results (11-20 of 35) with videos related to

Sort By:
Pageof 4
Eye (London, England)|March 30, 2024
An eye on equity: faricimab-driven health equity improvements in diabetic macular oedema using a distributional cost-effectiveness analysis from a UK societal perspectiveAurelie Meunier, Oyin Opeifa, Louise Longworth, et al.
Eye (London, England)|January 10, 2026
Early detection of neovascular age-related macular degeneration in the second eye reduces intravitreal treatment burden: FASBAT report 2Rachel L W Hanson, Archana Airody, Sobha Sivaprasad, et al.
Ophthalmology. Retina|March 20, 2026
PULSAR: Clinical Outcomes of Aflibercept 8 mg with Extended Dosing and 2 mg in nAMD in Subgroups Defined by Baseline CharacteristicsRichard P Gale, Anat Loewenstein, Xin Zhang, et al.
Ophthalmology. Retina|December 30, 2021
Efficacy Outcomes of Brolucizumab Versus Aflibercept in Neovascular Age-Related Macular Degeneration Patients with Early Residual FluidRishi P Singh, Chirag Jhaveri, Charles C Wykoff, et al.
Clinical Ophthalmology (Auckland, N.Z.)|June 18, 2020
Providing a Safe and Effective Intravitreal Treatment Service: Strategies for Service DeliveryWinfried Amoaku, Clare Bailey, Louise Downey, et al.
Ophthalmology. Retina|January 3, 2024
Improved Structure and Function in Early-Detected Second-Eye Neovascular Age-Related Macular Degeneration: FASBAT/Early Detection of Neovascular Age-Related Macular Degeneration Report 1Richard P Gale, Archana Airody, Sobha Sivaprasad, et al.
Clinical Ophthalmology (Auckland, N.Z.)|November 30, 2017
Aflibercept treatment for neovascular AMD beyond the first year: consensus recommendations by a UK expert roundtable panel, 2017 updatePraveen J Patel, Helen Devonport, Sobha Sivaprasad, et al.
Eye (London, England)|January 5, 2020
Recommendations by a UK expert panel on an aflibercept treat-and-extend pathway for the treatment of neovascular age-related macular degenerationAdam H Ross, Louise Downey, Helen Devonport, et al.
Scientific Reports|March 27, 2023
Assessing the structure of the posterior visual pathway in bilateral macular degenerationHolly D H Brown, Richard P Gale, André D Gouws, et al.
Eye (London, England)|March 31, 2019
Action on neovascular age-related macular degeneration (nAMD): recommendations for management and service provision in the UK hospital eye serviceRichard P Gale, Sajjad Mahmood, Helen Devonport, et al.
Pageof 4